Anti-TNF Therapy in Spondyloarthritis and Related Diseases, Impact on the Immune System and Prediction of Treatment Responses

References 295

1. 1.

   This reference’s wording can’t be shown under the paper’s licence.

   Not in our library

2. 2.

   This reference’s wording can’t be shown under the paper’s licence.

   Not in our library

3. 3.

   This reference’s wording can’t be shown under the paper’s licence.

   Not in our library

4. 4.

   This reference’s wording can’t be shown under the paper’s licence.

   Not in our library

5. 5.

   This reference’s wording can’t be shown under the paper’s licence.

   Not in our library

6. 6.

   This reference’s wording can’t be shown under the paper’s licence.

   Not in our library

7. 7.
   Metabolic Profiling Predicts Response to Anti–Tumor Necrosis Factor α Therapy in Patients With Rheumatoid Arthritis · 2013

   No notice
8. 8.

   This reference’s wording can’t be shown under the paper’s licence.

   Not in our library

9. 9.

   This reference’s wording can’t be shown under the paper’s licence.

   Not in our library

10. 10.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

11. 11.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

12. 12.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

13. 13.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

14. 14.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

15. 15.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

16. 16.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

17. 17.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

18. 18.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

19. 19.
    Pervasive Sharing of Genetic Effects in Autoimmune Disease · 2011

    No notice
20. 20.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

21. 21.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

22. 22.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

23. 23.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

24. 24.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

25. 25.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

26. 26.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

27. 27.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

28. 28.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

29. 29.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

30. 30.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

31. 31.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

32. 32.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

33. 33.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

34. 34.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

35. 35.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

36. 36.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

37. 37.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

38. 38.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

39. 39.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

40. 40.
    The IL23R R381Q Gene Variant Protects against Immune-Mediated Diseases by Impairing IL-23-Induced Th17 Effector Response in Humans · 2011

    No notice
41. 41.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

42. 42.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

43. 43.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

44. 44.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

45. 45.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

46. 46.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

47. 47.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

48. 48.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

49. 49.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

50. 50.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

51. 51.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

52. 52.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

53. 53.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

54. 54.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

55. 55.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

56. 56.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

57. 57.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

58. 58.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

59. 59.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

60. 60.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

61. 61.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

62. 62.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

63. 63.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

64. 64.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

65. 65.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

66. 66.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

67. 67.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

68. 68.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

69. 69.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

70. 70.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

71. 71.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

72. 72.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

73. 73.
    Ectopic Lymphoid Structures Support Ongoing Production of Class-Switched Autoantibodies in Rheumatoid Synovium · 2009

    No notice
74. 74.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

75. 75.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

76. 76.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

77. 77.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

78. 78.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

79. 79.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

80. 80.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

81. 81.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

82. 82.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

83. 83.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

84. 84.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

85. 85.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

86. 86.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

87. 87.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

88. 88.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

89. 89.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

90. 90.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

91. 91.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

92. 92.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

93. 93.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

94. 94.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

95. 95.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

96. 96.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

97. 97.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

98. 98.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

99. 99.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

100. 100.

     This reference’s wording can’t be shown under the paper’s licence.

     Not in our library

101. 101.

     This reference’s wording can’t be shown under the paper’s licence.

     Not in our library

102. 102.

     This reference’s wording can’t be shown under the paper’s licence.

     Not in our library

103. 103.

     This reference’s wording can’t be shown under the paper’s licence.

     Not in our library

104. 104.

     This reference’s wording can’t be shown under the paper’s licence.

     Not in our library

105. 105.
     Advances in Human B Cell Phenotypic Profiling · 2012

     No notice
106. 106.

     This reference’s wording can’t be shown under the paper’s licence.

     Not in our library

107. 107.

     This reference’s wording can’t be shown under the paper’s licence.

     Not in our library

108. 108.

     This reference’s wording can’t be shown under the paper’s licence.

     Not in our library

109. 109.

     This reference’s wording can’t be shown under the paper’s licence.

     Not in our library

110. 110.

     This reference’s wording can’t be shown under the paper’s licence.

     Not in our library

111. 111.

     This reference’s wording can’t be shown under the paper’s licence.

     Not in our library

112. 112.

     This reference’s wording can’t be shown under the paper’s licence.

     Not in our library

113. 113.

     This reference’s wording can’t be shown under the paper’s licence.

     Not in our library

114. 114.

     This reference’s wording can’t be shown under the paper’s licence.

     Not in our library

115. 115.

     This reference’s wording can’t be shown under the paper’s licence.

     Not in our library

116. 116.

     This reference’s wording can’t be shown under the paper’s licence.

     Not in our library

117. 117.

     This reference’s wording can’t be shown under the paper’s licence.

     Not in our library

118. 118.

     This reference’s wording can’t be shown under the paper’s licence.

     Not in our library

119. 119.

     This reference’s wording can’t be shown under the paper’s licence.

     Not in our library

120. 120.

     This reference’s wording can’t be shown under the paper’s licence.

     Not in our library

121. 121.

     This reference’s wording can’t be shown under the paper’s licence.

     Not in our library

122. 122.

     This reference’s wording can’t be shown under the paper’s licence.

     Not in our library

123. 123.

     This reference’s wording can’t be shown under the paper’s licence.

     Not in our library

124. 124.

     This reference’s wording can’t be shown under the paper’s licence.

     Not in our library

125. 125.

     This reference’s wording can’t be shown under the paper’s licence.

     Not in our library

126. 126.

     This reference’s wording can’t be shown under the paper’s licence.

     Not in our library

127. 127.

     This reference’s wording can’t be shown under the paper’s licence.

     Not in our library

128. 128.

     This reference’s wording can’t be shown under the paper’s licence.

     Not in our library

129. 129.

     This reference’s wording can’t be shown under the paper’s licence.

     Not in our library

130. 130.

     This reference’s wording can’t be shown under the paper’s licence.

     Not in our library

131. 131.

     This reference’s wording can’t be shown under the paper’s licence.

     Not in our library

132. 132.

     This reference’s wording can’t be shown under the paper’s licence.

     Not in our library

133. 133.

     This reference’s wording can’t be shown under the paper’s licence.

     Not in our library

134. 134.

     This reference’s wording can’t be shown under the paper’s licence.

     Not in our library

135. 135.

     This reference’s wording can’t be shown under the paper’s licence.

     Not in our library

136. 136.

     This reference’s wording can’t be shown under the paper’s licence.

     Not in our library

137. 137.

     This reference’s wording can’t be shown under the paper’s licence.

     Not in our library

138. 138.

     This reference’s wording can’t be shown under the paper’s licence.

     Not in our library

139. 139.

     This reference’s wording can’t be shown under the paper’s licence.

     Not in our library

140. 140.

     This reference’s wording can’t be shown under the paper’s licence.

     Not in our library

141. 141.

     This reference’s wording can’t be shown under the paper’s licence.

     Not in our library

142. 142.

     This reference’s wording can’t be shown under the paper’s licence.

     Not in our library

143. 143.

     This reference’s wording can’t be shown under the paper’s licence.

     Not in our library

144. 144.

     This reference’s wording can’t be shown under the paper’s licence.

     Not in our library

145. 145.

     This reference’s wording can’t be shown under the paper’s licence.

     Not in our library

146. 146.

     This reference’s wording can’t be shown under the paper’s licence.

     Not in our library

147. 147.

     This reference’s wording can’t be shown under the paper’s licence.

     Not in our library

148. 148.

     This reference’s wording can’t be shown under the paper’s licence.

     Not in our library

149. 149.

     This reference’s wording can’t be shown under the paper’s licence.

     Not in our library

150. 150.

     This reference’s wording can’t be shown under the paper’s licence.

     Not in our library

151. 151.

     This reference’s wording can’t be shown under the paper’s licence.

     Not in our library

152. 152.

     This reference’s wording can’t be shown under the paper’s licence.

     Not in our library

153. 153.

     This reference’s wording can’t be shown under the paper’s licence.

     Not in our library

154. 154.

     This reference’s wording can’t be shown under the paper’s licence.

     Not in our library

155. 155.

     This reference’s wording can’t be shown under the paper’s licence.

     Not in our library

156. 156.

     This reference’s wording can’t be shown under the paper’s licence.

     Not in our library

157. 157.

     This reference’s wording can’t be shown under the paper’s licence.

     Not in our library

158. 158.

     This reference’s wording can’t be shown under the paper’s licence.

     Not in our library

159. 159.

     This reference’s wording can’t be shown under the paper’s licence.

     Not in our library

160. 160.

     This reference’s wording can’t be shown under the paper’s licence.

     Not in our library

161. 161.

     This reference’s wording can’t be shown under the paper’s licence.

     Not in our library

162. 162.

     This reference’s wording can’t be shown under the paper’s licence.

     Not in our library

163. 163.

     This reference’s wording can’t be shown under the paper’s licence.

     Not in our library

164. 164.

     This reference’s wording can’t be shown under the paper’s licence.

     Not in our library

165. 165.

     This reference’s wording can’t be shown under the paper’s licence.

     Not in our library

166. 166.

     This reference’s wording can’t be shown under the paper’s licence.

     Not in our library

167. 167.

     This reference’s wording can’t be shown under the paper’s licence.

     Not in our library

168. 168.

     This reference’s wording can’t be shown under the paper’s licence.

     Not in our library

169. 169.

     This reference’s wording can’t be shown under the paper’s licence.

     Not in our library

170. 170.

     This reference’s wording can’t be shown under the paper’s licence.

     Not in our library

171. 171.

     This reference’s wording can’t be shown under the paper’s licence.

     Not in our library

172. 172.

     This reference’s wording can’t be shown under the paper’s licence.

     Not in our library

173. 173.
     Increasing levels of circulating Th17 cells and interleukin-17 in rheumatoid arthritis patients with an inadequate response to anti-TNF-α therapy · 2011

     No notice
174. 174.

     This reference’s wording can’t be shown under the paper’s licence.

     Not in our library

175. 175.

     This reference’s wording can’t be shown under the paper’s licence.

     Not in our library

176. 176.

     This reference’s wording can’t be shown under the paper’s licence.

     Not in our library

177. 177.

     This reference’s wording can’t be shown under the paper’s licence.

     Not in our library

178. 178.

     This reference’s wording can’t be shown under the paper’s licence.

     Not in our library

179. 179.
     Genome-Wide Association Study and Gene Expression Analysis Identifies CD84 as a Predictor of Response to Etanercept Therapy in Rheumatoid Arthritis · 2013

     No notice
180. 180.

     This reference’s wording can’t be shown under the paper’s licence.

     Not in our library

181. 181.

     This reference’s wording can’t be shown under the paper’s licence.

     Not in our library

182. 182.

     This reference’s wording can’t be shown under the paper’s licence.

     Not in our library

183. 183.

     This reference’s wording can’t be shown under the paper’s licence.

     Not in our library

184. 184.

     This reference’s wording can’t be shown under the paper’s licence.

     Not in our library

185. 185.

     This reference’s wording can’t be shown under the paper’s licence.

     Not in our library

186. 186.

     This reference’s wording can’t be shown under the paper’s licence.

     Not in our library

187. 187.

     This reference’s wording can’t be shown under the paper’s licence.

     Not in our library

188. 188.

     This reference’s wording can’t be shown under the paper’s licence.

     Not in our library

189. 189.

     This reference’s wording can’t be shown under the paper’s licence.

     Not in our library

190. 190.

     This reference’s wording can’t be shown under the paper’s licence.

     Not in our library

191. 191.

     This reference’s wording can’t be shown under the paper’s licence.

     Not in our library

192. 192.

     This reference’s wording can’t be shown under the paper’s licence.

     Not in our library

193. 193.

     This reference’s wording can’t be shown under the paper’s licence.

     Not in our library

194. 194.

     This reference’s wording can’t be shown under the paper’s licence.

     Not in our library

195. 195.

     This reference’s wording can’t be shown under the paper’s licence.

     Not in our library

196. 196.

     This reference’s wording can’t be shown under the paper’s licence.

     Not in our library

197. 197.

     This reference’s wording can’t be shown under the paper’s licence.

     Not in our library

198. 198.

     This reference’s wording can’t be shown under the paper’s licence.

     Not in our library

199. 199.

     This reference’s wording can’t be shown under the paper’s licence.

     Not in our library

200. 200.

     This reference’s wording can’t be shown under the paper’s licence.

     Not in our library

201. 201.

     This reference’s wording can’t be shown under the paper’s licence.

     Not in our library

202. 202.

     This reference’s wording can’t be shown under the paper’s licence.

     Not in our library

203. 203.

     This reference’s wording can’t be shown under the paper’s licence.

     Not in our library

204. 204.

     This reference’s wording can’t be shown under the paper’s licence.

     Not in our library

205. 205.
     Ectopic lymphoid follicles: inducible centres for generating antigen‐specific immune responses within tissues · 2015

     No notice
206. 206.

     This reference’s wording can’t be shown under the paper’s licence.

     Not in our library

207. 207.

     This reference’s wording can’t be shown under the paper’s licence.

     Not in our library

208. 208.

     This reference’s wording can’t be shown under the paper’s licence.

     Not in our library

209. 209.

     This reference’s wording can’t be shown under the paper’s licence.

     Not in our library

210. 210.

     This reference’s wording can’t be shown under the paper’s licence.

     Not in our library

211. 211.

     This reference’s wording can’t be shown under the paper’s licence.

     Not in our library

212. 212.

     This reference’s wording can’t be shown under the paper’s licence.

     Not in our library

213. 213.

     This reference’s wording can’t be shown under the paper’s licence.

     Not in our library

214. 214.

     This reference’s wording can’t be shown under the paper’s licence.

     Not in our library

215. 215.

     This reference’s wording can’t be shown under the paper’s licence.

     Not in our library

216. 216.

     This reference’s wording can’t be shown under the paper’s licence.

     Not in our library

217. 217.
     The expanding family of regulatory B cells · 2015

     No notice
218. 218.

     This reference’s wording can’t be shown under the paper’s licence.

     Not in our library

219. 219.

     This reference’s wording can’t be shown under the paper’s licence.

     Not in our library

220. 220.

     This reference’s wording can’t be shown under the paper’s licence.

     Not in our library

221. 221.

     This reference’s wording can’t be shown under the paper’s licence.

     Not in our library

222. 222.

     This reference’s wording can’t be shown under the paper’s licence.

     Not in our library

223. 223.

     This reference’s wording can’t be shown under the paper’s licence.

     Not in our library

224. 224.

     This reference’s wording can’t be shown under the paper’s licence.

     Not in our library

225. 225.
     Baseline predictors of response and discontinuation of tumor necrosis factor-alpha blocking therapy in ankylosing spondylitis: a prospective longitudinal observational cohort study · 2011

     No notice
226. 226.

     This reference’s wording can’t be shown under the paper’s licence.

     Not in our library

227. 227.

     This reference’s wording can’t be shown under the paper’s licence.

     Not in our library

228. 228.

     This reference’s wording can’t be shown under the paper’s licence.

     Not in our library

229. 229.

     This reference’s wording can’t be shown under the paper’s licence.

     Not in our library

230. 230.

     This reference’s wording can’t be shown under the paper’s licence.

     Not in our library

231. 231.

     This reference’s wording can’t be shown under the paper’s licence.

     Not in our library

232. 232.

     This reference’s wording can’t be shown under the paper’s licence.

     Not in our library

233. 233.

     This reference’s wording can’t be shown under the paper’s licence.

     Not in our library

234. 234.

     This reference’s wording can’t be shown under the paper’s licence.

     Not in our library

235. 235.

     This reference’s wording can’t be shown under the paper’s licence.

     Not in our library

236. 236.

     This reference’s wording can’t be shown under the paper’s licence.

     Not in our library

237. 237.

     This reference’s wording can’t be shown under the paper’s licence.

     Not in our library

238. 238.

     This reference’s wording can’t be shown under the paper’s licence.

     Not in our library

239. 239.

     This reference’s wording can’t be shown under the paper’s licence.

     Not in our library

240. 240.

     This reference’s wording can’t be shown under the paper’s licence.

     Not in our library

241. 241.

     This reference’s wording can’t be shown under the paper’s licence.

     Not in our library

242. 242.

     This reference’s wording can’t be shown under the paper’s licence.

     Not in our library

243. 243.

     This reference’s wording can’t be shown under the paper’s licence.

     Not in our library

244. 244.

     This reference’s wording can’t be shown under the paper’s licence.

     Not in our library

245. 245.

     This reference’s wording can’t be shown under the paper’s licence.

     Not in our library

246. 246.

     This reference’s wording can’t be shown under the paper’s licence.

     Not in our library

247. 247.

     This reference’s wording can’t be shown under the paper’s licence.

     Not in our library

248. 248.

     This reference’s wording can’t be shown under the paper’s licence.

     Not in our library

249. 249.

     This reference’s wording can’t be shown under the paper’s licence.

     Not in our library

250. 250.

     This reference’s wording can’t be shown under the paper’s licence.

     Not in our library

251. 251.

     This reference’s wording can’t be shown under the paper’s licence.

     Not in our library

252. 252.

     This reference’s wording can’t be shown under the paper’s licence.

     Not in our library

253. 253.

     This reference’s wording can’t be shown under the paper’s licence.

     Not in our library

254. 254.

     This reference’s wording can’t be shown under the paper’s licence.

     Not in our library

255. 255.

     This reference’s wording can’t be shown under the paper’s licence.

     Not in our library

256. 256.
     Ectopic Lymphoid Structures: Powerhouse of Autoimmunity · 2016

     No notice
257. 257.

     This reference’s wording can’t be shown under the paper’s licence.

     Not in our library

258. 258.

     This reference’s wording can’t be shown under the paper’s licence.

     Not in our library

259. 259.

     This reference’s wording can’t be shown under the paper’s licence.

     Not in our library

260. 260.

     This reference’s wording can’t be shown under the paper’s licence.

     Not in our library

261. 261.

     This reference’s wording can’t be shown under the paper’s licence.

     Not in our library

262. 262.

     This reference’s wording can’t be shown under the paper’s licence.

     Not in our library

263. 263.

     This reference’s wording can’t be shown under the paper’s licence.

     Not in our library

264. 264.

     This reference’s wording can’t be shown under the paper’s licence.

     Not in our library

265. 265.

     This reference’s wording can’t be shown under the paper’s licence.

     Not in our library

266. 266.

     This reference’s wording can’t be shown under the paper’s licence.

     Not in our library

267. 267.

     This reference’s wording can’t be shown under the paper’s licence.

     Not in our library

268. 268.

     This reference’s wording can’t be shown under the paper’s licence.

     Not in our library

269. 269.

     This reference’s wording can’t be shown under the paper’s licence.

     Not in our library

270. 270.

     This reference’s wording can’t be shown under the paper’s licence.

     Not in our library

271. 271.

     This reference’s wording can’t be shown under the paper’s licence.

     Not in our library

272. 272.

     This reference’s wording can’t be shown under the paper’s licence.

     Not in our library

273. 273.

     This reference’s wording can’t be shown under the paper’s licence.

     Not in our library

274. 274.

     This reference’s wording can’t be shown under the paper’s licence.

     Not in our library

275. 275.

     This reference’s wording can’t be shown under the paper’s licence.

     Not in our library

276. 276.
     Unique transcriptome signatures and GM-CSF expression in lymphocytes from patients with spondyloarthritis · 2017

     No notice
277. 277.

     This reference’s wording can’t be shown under the paper’s licence.

     Not in our library

278. 278.

     This reference’s wording can’t be shown under the paper’s licence.

     Not in our library

279. 279.

     This reference’s wording can’t be shown under the paper’s licence.

     Not in our library

280. 280.

     This reference’s wording can’t be shown under the paper’s licence.

     Not in our library

281. 281.

     This reference’s wording can’t be shown under the paper’s licence.

     Not in our library

282. 282.

     This reference’s wording can’t be shown under the paper’s licence.

     Not in our library

283. 283.

     This reference’s wording can’t be shown under the paper’s licence.

     Not in our library

284. 284.

     This reference’s wording can’t be shown under the paper’s licence.

     Not in our library

285. 285.

     This reference’s wording can’t be shown under the paper’s licence.

     Not in our library

286. 286.

     This reference’s wording can’t be shown under the paper’s licence.

     Not in our library

287. 287.

     This reference’s wording can’t be shown under the paper’s licence.

     Not in our library

288. 288.

     This reference’s wording can’t be shown under the paper’s licence.

     Not in our library

289. 289.

     This reference’s wording can’t be shown under the paper’s licence.

     Not in our library

290. 290.

     This reference’s wording can’t be shown under the paper’s licence.

     Not in our library

291. 291.

     This reference’s wording can’t be shown under the paper’s licence.

     Not in our library

292. 292.

     This reference’s wording can’t be shown under the paper’s licence.

     Not in our library

293. 293.

     This reference’s wording can’t be shown under the paper’s licence.

     Not in our library

294. 294.

     This reference’s wording can’t be shown under the paper’s licence.

     Not in our library

295. 295.

     This reference’s wording can’t be shown under the paper’s licence.

     Not in our library

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.